His primary areas of study are Surgery, Colorectal cancer, Internal medicine, Oncology and Cancer. His research integrates issues of Clinical trial and Palliative care in his study of Surgery. His Colorectal cancer study integrates concerns from other disciplines, such as Rectum, Randomized controlled trial and Fluorouracil.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology. His work carried out in the field of Oncology brings together such families of science as Cetuximab, Epidemiology, Relative risk, Cumulative dose and Adjuvant therapy. Within one scientific family, Bengt Glimelius focuses on topics pertaining to Cohort study under Cancer, and may sometimes address concerns connected to Pediatrics.
His primary areas of investigation include Internal medicine, Colorectal cancer, Oncology, Surgery and Cancer. His work in Internal medicine covers topics such as Gastroenterology which are related to areas like Phases of clinical research. The concepts of his Colorectal cancer study are interwoven with issues in Rectum, Chemoradiotherapy and Randomized controlled trial.
His Oncology research incorporates themes from Irinotecan, Capecitabine, KRAS, Hazard ratio and Cohort. His Surgery research incorporates elements of Clinical trial and Palliative care. He has included themes like Preoperative care and Total mesorectal excision in his Radiation therapy study.
Bengt Glimelius spends much of his time researching Colorectal cancer, Internal medicine, Oncology, Chemotherapy and Radiation therapy. His study in Colorectal cancer is interdisciplinary in nature, drawing from both Adjuvant chemotherapy, Chemoradiotherapy, Surgery and Clinical trial. As part of his studies on Surgery, Bengt Glimelius often connects relevant subjects like Total mesorectal excision.
His work in Oxaliplatin, Randomized controlled trial, Hazard ratio, Cancer and Cohort is related to Internal medicine. His work on Adjuvant as part of his general Oncology study is frequently connected to In patient, thereby bridging the divide between different branches of science. His studies in Radiation therapy integrate themes in fields like Neoadjuvant therapy and Stage.
Bengt Glimelius mainly focuses on Internal medicine, Colorectal cancer, Oncology, Surgery and Chemoradiotherapy. His Colorectal cancer research is multidisciplinary, relying on both Locally advanced, Radiation therapy, Chemotherapy, Young adult and Survival rate. Bengt Glimelius combines subjects such as Statement, Cancer and Expert consensus with his study of Radiation therapy.
His Oncology research includes themes of Microsatellite instability, Proportional hazards model, Stage, Stage ii and Confounding. In his work, Clinical endpoint is strongly intertwined with Total mesorectal excision, which is a subfield of Surgery. His Chemoradiotherapy study combines topics in areas such as Neoadjuvant therapy, Chemo-radiotherapy, Progression-free survival and Rectal cancer surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston.
The Lancet (2008)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H J Schmoll;E Van Cutsem;A Stein;V Valentini.
Annals of Oncology (2012)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg.
Lancet Oncology (2011)
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
B Glimelius;K Ekström;K Hoffman;W Graf.
Annals of Oncology (1997)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston.
Lancet Oncology (2013)
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
B Glimelius;Katarina Hoffman;P-O Sjoden;G Jacobsson.
Annals of Oncology (1996)
Swedish rectal cancer trial : Long lasting benefits from radiotherapy on survival and local recurrence rate
Joakim Folkesson;Helgi Birgisson;Lars Pahlman;Bjorn Cedermark.
Journal of Clinical Oncology (2005)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Glimelius;L. Påhlman;A. Cervantes.
Annals of Oncology (2010)
Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial.
Lars Påhlman;Bengt Glimelius.
Annals of Surgery (1990)
Sexually Transmitted Infection as a Cause of Anal Cancer
Morten Frisch;Bengt Glimelius;Adriaan J.C. van den Brule;Jan Wohlfahrt.
The New England Journal of Medicine (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: